abrdn Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

abrdn Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,349	Closed	-$553K	–	381
2014 Q4	$553K	Sell	1,349 -1,747	-56%	-$687K	﹤0.01%	319
2014 Q3	$1.12M	Sell	3,096 -273	-8%	-$91.5K	﹤0.01%	281
2014 Q2	$952K	Sell	3,369 -127	-4%	-$37.6K	﹤0.01%	307
2014 Q1	$1.05M	Buy	3,496 +35	+1%	+$10.8K	0.01%	253
2013 Q4	$953K	Buy	3,461 +109	+3%	+$31.4K	0.01%	288
2013 Q3	$1.05M	Buy	3,352 +54	+2%	+$14.2K	0.01%	254
2013 Q2	$742K	Buy	+3,298	New	+$768K	﹤0.01%	280

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

abrdn Investment Management's REGN Position: Q1 2015 in Review

abrdn Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2015, closing a stake of 1,349 shares — an estimated $553K sold.

abrdn Investment Management first reported a position in REGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.12M in Q3 2014. 509 funds tracked by Wall St. Rank hold REGN as of Q1 2015.

abrdn Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
abrdn Investment Management sold 1,349 Regeneron Pharmaceuticals shares in Q1 2015, an estimated $553K.
abrdn Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 7 quarters.
abrdn Investment Management's Regeneron Pharmaceuticals position peaked at $1.12M in Q3 2014.
509 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2015.

Based on abrdn Investment Management's 13F filing for Q1 2015, filed 15 May 2015.